R&D period and difficulty are different.
Usually, a drug includes anti-tumor drugs, and the research and development cycle is usually 8~ 14 years. In particular, the research and development of new anticancer drugs has a high failure rate, and it must go through the first, second and third clinical trials and be verified by a large number of people before it can be listed.
Medical equipment is different. There are three types of medical equipment. Only two or three kinds need some clinical trials, but they are only verified by small samples. Moreover, most of the inspection equipment in the hospital belongs to auxiliary diagnosis or inspection equipment, which generally belongs to a class of medical devices and does not need clinical trials, so the overall cycle is not one and a half weeks.
Different technical barriers
The listing of a brand-new anticancer drug can be said to have attracted worldwide attention. Pharmaceutical companies also adopt strong patents and technical barriers, which almost seal any gap related to them and will not exploit loopholes for others. Even if someone bypassed the patent, most of them copied it on the basis of others. Moreover, few generic drugs are more effective than the original drugs. In this way, although patients can choose more drugs, they have not actually made progress.
Different from medical devices, core technologies involve physics, chemistry, mathematics, biology, medicine, and even machinery, engineering and other fields. Technological innovation in any field is likely to promote the by going up one flight of stairs of a certain type of medical equipment. Such as nanotechnology, 3D printing technology and so on.
Price problem
The research and development of new drugs can be described as a narrow escape. New drug research and development personnel spend a lot of human and financial resources and bear the risk of a large number of investment failures. Only when a new drug can be successfully listed can it be imagined that it is expensive. However, medical devices are usually developed based on new technologies that have been formed, and the success rate is very high. Because it is only used for inspection and can be reused, the charging standard is stipulated by the state and there is great market competition, so the inspector will not bear the high price.
Brief introduction of Dr. Yao
Doctor, deputy director pharmacist, senior nutritionist, with 1 1 year experience in medication guidance, nutrition consultation and health management. No medicine, no doctor, advocate healthy life, no disease, no doctor!